Solubilising excipients that are employed to deliberately increase the solubility of a poorly soluble API are not discussed here, as these are not considered to be relevant formulation approach for highly soluble BCS Class 1 and 3 compounds (a summary of such effects can be foundin Sjogren et al. [5]).